ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2013

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

9,599Medicare Part D Prescriptions Filled, Including Refills

Rank: 1033 out of 6782

$549K Total Retail Price of All Prescriptions

Rank: 1166 out of 6782

451 Patients Receiving at Least One Drug in Part D
89% Patients 65 Years and Older
16% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg 81928cdb0ebe162ff75cf405bfacadd396bf3ec84bc467b6f3e612dd63daa776 Average for
this specialty
in California
Lower avg 72b1978e1dcc0b845f89d17d692cfff7aeaf8d8bce70310d8bfc535db2daf62a

Schedule Two
Controlled Substances

3% of this provider’s 451 patients filled at least one prescription for a schedule two drug, compared to an average of 3%.

Schedule Three
Controlled Substances

21% of this provider’s 451 patients filled at least one prescription for a schedule three drug, compared to an average of 12%.

Brand Name Drugs

20% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$57 was the average price of a prescription from this provider, compared to $64 among peers.

Prescriptions per Patient

21 is the average number of prescriptions (including refills) per patient, compared to an average of 16.


This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

B

A benzodiazepine, or tranquilizer. More » The American Geriatrics Society says these drugs increase the risk of cognitive impairment, delirium, falls and fractures in older adults.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled with Refills Prescriptions
to 65+
Patients Recieving this Drug Category For this Prescriber For All Prescribers in
This Specialty in California
HYDROCODONE-ACETAMINOPHEN 443 306 80 S3 1 6
LEVOTHYROXINE SODIUM 428 403 94 2 3
LISINOPRIL 396 351 84 3 4
SIMVASTATIN 352 310 73 4 1
OMEPRAZOLE 277 249 70 5 7
FUROSEMIDE 227 216 43 6 11
ATORVASTATIN CALCIUM 226 195 57 7 5
LOVASTATIN 192 187* 40 8 16
ATENOLOL 192 164 46 8 9
POTASSIUM CHLORIDE 183 160 44 10 30
LIOTHYRONINE SODIUM 178 173* 33 11 329
TAMSULOSIN HCL 172 155 36 12 21
AMLODIPINE BESYLATE 160 148 39 13 2
ZOLPIDEM TARTRATE 157 116 32 14 18
HYDROCHLOROTHIAZIDE 149 149 35 15 12
METFORMIN HCL 149 127 35 15 8
ALPRAZOLAM 141 92 29 B 17 37
METOPROLOL TARTRATE 131 126* 26 18 13
WARFARIN SODIUM 127 96 23 19 17
METOPROLOL SUCCINATE 123 106 23 20 22
FLUTICASONE PROPIONATE 113 95 51 21 24
CLONIDINE HCL 112 107* 16 22 60
CARVEDILOL 97 77 16 23 23
ESTRADIOL 81 76* 15 R 24 158
TRAMADOL HCL 78 73* 22 25 32
CLOPIDOGREL 77 77 18 26 19
CIPROFLOXACIN HCL 73 68* 60 27 70
CITALOPRAM HBR 73 61 17 27 42
GLYBURIDE 73 59 14 R 27 90
GABAPENTIN 72 41 19 30 15
LOSARTAN POTASSIUM 71 71 17 31 10
NAMENDA 70 70 12 32 36
TRIAMTERENE-HCTZ 68 68 15 33 59
PAROXETINE HCL 66 61* 11 34 77
LORAZEPAM 64 34 13 B 35 29
PROAIR HFA 64 34 31 35 34
PREDNISONE 61 45 36 37 57
PREMARIN 61 <11 <11 R 37 167
TRAZODONE HCL 60 13 12 39 50
BENAZEPRIL HCL 59 59 12 40 27
CYMBALTA 57 34 11 41 69
ISOSORBIDE MONONITRATE ER 52 <11 <11 42 68
GLIPIZIDE 52 <11 <11 42 25
ESCITALOPRAM OXALATE 50 <11 <11 44 53
DIOVAN 50 <11 <11 44 26
About This Data

Prescribing data from Medicare’s prescription drug benefit, known as Part D, was compiled and released by the Centers for Medicare and Medicaid Services, the federal agency that oversees the program. ProPublica combined that data with additional information released by CMS. The data for 2013 includes nearly 1.4 billion prescriptions written by 1.3 million doctors, nurses and other providers. This database lists about 410,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths of these prescriptions went to patients 65 and older; the rest were for disabled patients Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to checkup@propublica.org and we will update your information. If you have other questions about this data, send a note to checkup@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 12, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.